Functional imaging and circulating biomarkers of response to regorafenib in treatment-refractory metastatic colorectal cancer patients in a prospective phase II study
Work
Year: 2017
Type: article
Abstract: Objective Regorafenib demonstrated efficacy in patients with metastatic colorectal cancer (mCRC). Lack of predictive biomarkers, potential toxicities and cost-effectiveness concerns highlight the unme... more
Source: Gut
Institutions Royal Marsden NHS Foundation Trust, Institute of Cancer Research, Cancer Research UK, Royal Marsden Hospital, University of Padua
Cites: 32
Cited by: 65
Related to: 10
FWCI: 3.535
Citation percentile (by year/subfield): 99.99
Subfield: Cancer Research
Domain: Life Sciences
Sustainable Development Goal Good health and well-being
Open Access status: hybrid
APC paid (est): $3,246